Axsome Therapeutics Inc (AXSM)

Axsome Therapeutics Inc (AXSM) 財務データ

損益計算書

四半期ごと

*すべての数値は百万単位です

期間終了日	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
期間の長さ	3 か月	3 か月	3 か月	3 か月	3 か月
Revenues	23.77% 71.53	57.79	46.70	94.58	24.37
Operating Expenses	41.60% 169.80	119.91	111.76	100.95	81.99
Benefits Costs and Expenses	41.30% 170.51	120.67	114.49	103.21	85.61
Costs And Expenses	41.60% 169.80	119.91	111.76	100.95	84.29
Operating Income/Loss	58.20% -98.27	-62.12	-65.06	-6.374	-59.92
Income/Loss From Continuing Operations Before Tax	57.41% -98.98	-62.88	-67.79	-8.638	-61.24
Income Tax Expense/Benefit	52.06% -0.325	-0.678	-0.617	2.58	-
Income/Loss From Continuing Operations After Tax	58.61% -98.65	-62.20	-67.17	-11.22	-61.24
Net Income/Loss	58.61% -98.65	-62.20	-67.17	-11.22	-61.24
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	98.64% 0.6418	47.12	43.67	43.52	0.9407
Diluted Average Shares	98.64% 0.6418	47.12	43.67	43.52	0.9407
Basic Earnings Per Share	61.36% -2.13	-1.32	-1.54	-0.26	-1.43
Diluted Earnings Per Share	61.36% -2.13	-1.32	-1.54	-0.26	-1.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-